1. Introduction {#sec1}
===============

Genetics and environment contribute to the development of obesity and its associated disorders, including type 2 diabetes, metabolic syndrome, and cardiovascular disease [@bib1], [@bib2]. There are multiple genetic risk factors for obesity that contribute to the pathological effects of energy oversupply and/or decreased energy expenditure [@bib3]. However, the interactions between epigenetic changes and obesity in metabolically relevant tissues, such as liver, are not well understood. Many studies have focused on heritable epigenetic changes in response to environmental stress during gestation [@bib4], [@bib5]. For example, gestational over or undernutrition may lead to multiple generations of epigenetic modifications that promote increased caloric uptake and storage (the thrifty phenotype hypothesis [@bib6]). It is not as clear, however, whether overnutrition in adult animals leads to epigenetic modifications in individuals that contribute to the pathophysiology of obesity. Understanding gene-environment interactions that underpin obesity and type 2 diabetes is an important goal for designing successful interventions for weight loss and management of metabolic disease.

Epigenetic regulatory influences are manifested via non-sequence based mechanisms including, for example, DNA methylation, post-translational histone modifications, histone variants, ATP-dependent chromatin remodeling complexes, polycomb/trithorax protein complexes, and small and other non-coding RNAs (lncRNAs and miRNAs). These epigenetic marks constitute multiple layers of control for modulating chromatin structure, to provide genomic homeostasis, and to regulate gene expression [@bib7], [@bib8]. Unlike the primary DNA sequence of the human genome, which is more or less identical in every somatic cell type, epigenetic information varies between different cell types and even between individual cells [@bib7], [@bib8], [@bib9]. Furthermore, the epigenome undergoes dynamic change during development and across the adult age range and may be altered either as a requirement for, or as a consequence of, complex disease pathogenesis [@bib10]. Given the emerging significance of epigenetics in gene regulation and the potential influence of environment on obesity and diabetes [@bib11], there is substantial need to undertake a systematic dissection of the epigenome of metabolically relevant tissues as a consequence of obesogenic diets.

One particularly important epigenetic mark is DNA methylation. It has long been known that DNA can be chemically modified at CpG sequences by the addition of a methyl group on the 5 position of the cytosine pyrimidine ring and that these epigenetic marks can have a profound effect on gene expression [@bib12]. For example, highly methylated genomic regions are associated with repressed chromatin states. In contrast, unmethylated regions, especially CpG islands located within gene promoters, are broadly associated with active transcription [@bib13].

Of particular significance is the recent understanding that epigenetic changes in genome function can be triggered by environmental influences and that the resulting altered phenotypic states may be dynamic or sustainable and even heritable in a mitotic or meiotic fashion [@bib4]. Consequently, environmental stress, whether it be dietary, chemical, or any one of a myriad of other exposures, can potentially alter the homeostatic regulation of the genome to an extent that is both chronic, thereby potentially driving pathogenesis, and trans-generational. This is significant because it suggests that epigenetic changes in chromatin function as a result of diet-induced obesity can be sustained within the gene pool as an environmentally dependent heritable trait.

Despite the public health significance of adult obesity and the emerging importance of epigenetics, there is little information relating to the epigenomic response to elevated caloric intake and its role in the regulation of gene expression. In the present study, we test the hypothesis that a high fat diet alters hepatic DNA methylation, transcription, and gene expression patterns, and we explore the contribution of such changes to the pathophysiology of a high fat diet. We performed targeted DNA Methyl-seq and RNA-seq analyses of livers from mice placed on a standard chow or high fat diet. A small set of genes were both hypermethylated and downregulated after a high fat diet and were evaluated by chromatin immunoprecipitation assays to confirm the relationship between transcriptional rate and DNA methylation. *Phlda1* (Pleckstrin Homology Like Domain Family A Member 1, ascribed to multiple functions including regulation of apoptosis and adipogenesis) and *Onecut1* (One Cut Homeobox 1, a transcription factor important for liver development and adult liver function) displayed decreased transcriptional elongation as determined by differential recruitment of phosphorylated RNA pol II. A subset of co-regulated genes was identified by investigating nearest neighbors of *Phlda1* in a Bayesian network previously generated from F2 crossed mouse liver transcriptomic data [@bib14], [@bib15], [@bib16]. *Onecut1*, and *Foxa* family members (Forkhead Box A 1--3) were among several genes in the subnetwork that were decreased by a high fat diet and are important for liver development, liver phenotype, and lipid homeostasis [@bib17], [@bib18]. Furthermore, knockdown of *Phlda1* led to increased lipid droplet size. This observation was consistent with the whole animal knockout model of *Phlda1*, which presents with a phenotype including increased body mass and liver steatosis on a normal chow diet [@bib19]. We conclude that a high fat diet alters specific genetic loci epigenetically, which contributes to the pathophysiology of obesity.

2. Materials and methods {#sec2}
========================

2.1. Animals and diet {#sec2.1}
---------------------

Six-week-old male C57Bl/6J mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and housed at the University of Pittsburgh animal facility with *ad libitum* access to food and water. One week after arrival, the mice were exposed to a hypercaloric test high fat/high sucrose diet (HFD; 40% carbohydrate, 41% fat, 19% protein per calories; 4.4 kcal/g; \#TD.96001 Harlan Teklad, Madison, WI) or a matched test standard chow (low fat/low sucrose) diet (SCD; 67% carbohydrate, 13% fat, 20% protein per calories; 3.6 kcal/g; \#TD.110340 Harlan Teklad, Madison, WI) for 14 weeks, N = 7 for each diet. Animals were housed and cared for under the supervision of IACUC approved University of Pittsburgh. Weight and food intake was monitored 5 times weekly. A glucose tolerance test was performed as previously described [@bib20].

2.2. Reverse transcription PCR {#sec2.2}
------------------------------

Reverse transcription PCR (RT-PCR) was performed as previously described [@bib21]. The primer pairs used in this study are listed in [Supplementary Table 1](#appsec1){ref-type="sec"}. For pre-mRNA RT-PCR, RNA was treated with DNase, and control experiments were performed to ensure intergenic regions were not amplified in PCR reactions.

2.3. RNA and DNA analyses {#sec2.3}
-------------------------

After killing the mice, livers were harvested as previously described. Powdered liver was used to extract total RNA and DNA and prepared for RNAseq, RT-, and DNA methyl-seq analysis. RNA was extracted using Tri Reagent (Molecular Research Center, Cincinnati, OH), which was subsequently treated with DNase 1 (ThermoFisher, Waltham, MA).

2.4. RNAseq {#sec2.4}
-----------

RNA concentration and integrity were determined by Bioanalyzer using the RNA Nano Kit (Agilent Technologies, Santa Clara, CA). RNA-seq libraries were prepared using the TruSeq RNA Sample Prep Kit (Illumina, San Diego, CA) per the manufacturer\'s protocol. Briefly, mRNA was purified from total RNA using oligo dT magnetic beads, fragmented, and then reverse transcribed via random hexamers and SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, CA). Second strand cDNA was synthesized using a proprietary master mix. The double stranded cDNA was then blunt ended, the 3′ ends were adenylated, and indexed Illumina adaptors were ligated. DNA fragments were enriched by PCR using the following conditions: initial denaturation of 98 °C for 30 s, 15 cycles of 98 °C for 10 s, 60 °C for 30 s, and 72 °C for 30 s, followed by a final extension of 72 °C for 5 min. RNA-seq libraries were visualized by Bioanalyzer (Agilent) and quantified by qPCR. Libraries were bar-coded and pooled by quantity and sequenced via 50 bp single reads on a HiSeq2000 (Illumina). Reads were trimmed to include only bases 9--57 for quality purposes. Alignment was done to mm9 using Tophat with the Bowtie 1 option [@bib22], [@bib23]. The number of reads intersecting with each gene was calculated, one was added, and counts were log2 transformed. DESeq was used for differential expression testing [@bib24].

2.5. DNA Methyl-seq {#sec2.5}
-------------------

Liver tissue was homogenized via Tissue Lyser II (Qiagen) and DNA was extracted via DNeasy Blood and Tissue Kit (Qiagen) per manufacturer\'s instructions. DNA libraries were prepared as per the SureSelect^XT^ Methyl-Seq Target Enrichment System Protocol (Agilent) with a 9 cycle PCR post bisulfite conversion and a 6 cycle indexing PCR. SureSelect Mouse All Exon V1 52 Mbp was used for capture. Libraries were sequenced on a Hiseq2000 (Illumina) using 100 bp paired end reads. Quality and adaptor trimming were done using Trim Galore and alignment was performed using Bismark. Duplicates were removed. MethylSig was used for differential methylation analysis [@bib25], [@bib26]. The GEO accession number for this study is [GSE85425](ncbi-geo:GSE85425){#intref0010}.

2.6. Bioinformatics {#sec2.6}
-------------------

We queried a mouse liver Bayesian network of ∼9400 nodes and ∼18,500 edges generated from integrating genotype and liver expression values generated in animals from multiple F2 crosses of mice [@bib14], [@bib15], [@bib16]. *Phlda1* was a node in this network, and we generated a subnetwork of its nearest neighbors by including nodes within two path lengths (undirected) from *Phlda1*. Genes in close proximity to *Phlda1* in this subnetwork were predicted to be affected if expression of *Phlda1* would be perturbed.

2.7. Chromatin immunoprecipitation assay {#sec2.7}
----------------------------------------

The liver was extracted and finely minced with a razorblade or flash frozen in liquid nitrogen. The ChIP assay protocol derived for this study was a modification of one published earlier [@bib27], using components of the Millipore/Upstate ChIP kit (cat \#17-295), with some additional modifications as previously described [@bib21]. Standard curves were constructed using two-fold serial dilutions of the unbound DNA extracted from the fasted IgG treatment (2.5 μl) as a reference input. The abundance of the amplicons was expressed as a percentage of the total reference input after subtracting the signal from the control IgG group as previously described [@bib21].

2.8. 5-Azacytidine experiments in isolated mouse hepatocytes {#sec2.8}
------------------------------------------------------------

Mice on a standard chow diet were anesthetized, and the liver was perfused with 50 ml of preheated 37 °C perfusion buffer I (142 mM Sodium Chloride, 6.7 mM Potassium Chloride, 10 mM Hepes, 2.23 μM EGTA -- pH7.4), then with 50--100 mL of preheated 37 °C perfusion buffer II (152 mM Albumin, 67 mM Sodium Chloride, 6.7 mM Potassium Chloride, 100 mM Hepes, 19 mM Calcium Chloride, 0.02% Type IV collagenase (Sigma) -- pH7.6) at a flow rate of 8 ml/min. The liver was carefully excised and placed in 6 cm petri dish with ice-cold isolation media (RPMI, 10% Heat-inactivated FBS, Non-Essential Amino Acids, Sodium Pyruvate, Penicillin/Streptomycin, [l]{.smallcaps}-Glutamine). The liver was then manually disrupted and filtered through a gauze pad and the liquid was centrifuged at 4 °C at 400 rpm for 5 min. The pellet was re-suspended in isolation media, and 90% Percoll (GE Healthcare) was carefully added to cell suspension. Cells were centrifuged at 4 °C at 400 rpm for 10 min. The pellet was washed twice with isolation media, re-suspended in high glucose media (isolation media and 25 mM glucose), and the viability was calculated using trypan blue exclusion. Cells were plated on collagen-coated 6-well tissue culture plates at a density of 1.2 × 10^6^ live cells per well. After incubating for 1 h at 37 °C and 5% CO~2~, media and any floating cells were removed and replaced with fresh high glucose treatment media.

Cells were treated for 18 h with or without 10 μM 5-azacytidine (Sigma, St. Louis, MO) prior to harvesting and isolating total RNA as described above.

2.9. Adenovirus-mediated knockdown of hepatic *Phlda1* {#sec2.9}
------------------------------------------------------

Eight week-old C57BL6 male mice were injected retro-orbitally with 5 × 10^9^ pfu of control GFP-expressing adenovirus or adenovirus expressing an shRNA directed against *Phlda1* (VectorBiolabs, Malvern, PA) according to the method of Yardeni et al. [@bib28]. This method delivers adenovirus specifically to the liver with equal efficacy compared when compared to tail vein injection [@bib29], [@bib30]. After 2 weeks, the liver was collected.

2.10. Oil Red O stain and quantification of lipid droplet size by Image J {#sec2.10}
-------------------------------------------------------------------------

Liver samples were embedded in Tissue-Tek OCT Compound immediately after dissection, and the fresh frozen liver samples were cut in a cryostat, affixed to microscope slides, and air-dried at room temperature for 30 min. The liver sections were washed with 1 × PBS twice for 5 min, then stained in Oil Red O working solution for 1 h in the dark (Oil Red O stock solution: Oil Red O 500 mg, in 100 ml 60% triethyl-phosphate; and Oil Red O working solution: 15 ml deionized water added to ml 45 ml Oil Red O stock solution). The sections were rinsed with warm running tap water for 15 min and washed with PBS for 5 min. The air-dried sections were mounted with Fluroment G. The slides were then viewed under a Zeiss AxioImager light microscope. Photomicrographs of multiple fields of multiple fragments from five SC and 5 HFD male mice were imported into Image J and total red (representing neutral lipids) and lipid droplet size were quantified according to the method of Mehlem et al. [@bib31]

2.11. Statistics {#sec2.11}
----------------

All the data shown are means ± standard errors (SE) for the numbers of experiments indicated in the figure legends. Significance was determined by unpaired two-tailed *t* tests. Differences were considered significant if the p value was \<0.05.

3. Results {#sec3}
==========

3.1. RNA-seq and DNA Methyl-seq analysis {#sec3.1}
----------------------------------------

Seven C57BL/6 mice were placed on a standard chow or a hypercaloric high fat diet for 14 weeks. These animals displayed the expected increase in body weight and decrease in glucose tolerance, which was accounted for by increased calories rather than hyperphagia, as the amount of food consumed was identical between the two groups ([Figure S1](#appsec1){ref-type="sec"}). Total RNA and genomic DNA were isolated from the livers and RNAseq and Methylseq were performed. Summary statistics for RNA-seq and DNA Methyl-seq sequencing analyses are shown in [Supplemental Tables 2 and 3](#appsec1){ref-type="sec"}, respectively.

Methyl-seq results were first ranked by the lowest q value of the differential methylation scores. Data were filtered to identify differentially methylated CpG sites that were within 1,000 bp of the transcriptional start site (TSS) of known genes, with a q value less than 10^−4^, without regard to direction (hypermethylated and hypomethylated genes were treated equally). In addition, we found one gene (*Onecut1*) that stood out because of highly significantly suppressed expression in the RNAseq data and significantly differentially methylated CpG sites at multiple sites within 10,000 bp of the TSS and because of its importance to liver development [@bib18]. We note that the very stringent parameters used to identify differential Methyl-seq loci were often associated with CpG shores (defined as near CpG islands, and more likely than islands to contains regulatory alterations in DNA methylation [@bib32]) and were often imbedded in a larger grouping of less significantly differentially methylated regions (see [Supplemental Table 4](#appsec1){ref-type="sec"}). RNA-seq data were filtered by listing the top 600 genes with significantly differential expression by p value, without regard to direction. Seven genes were found that were both differentially methylated and differentially expressed ([Figure 1](#fig1){ref-type="fig"}A). The seven genes had differentially methylated sites that ranged from 5 to 22% different ([Supplemental Table 4](#appsec1){ref-type="sec"}). We were surprised by the relatively small number of overlapping genes and found that we could dramatically increase the number by decreasing the stringency of inclusion of genes associated with differentially methylated CpGs. If we included differentially methylated CpGs within 10,000 bp of transcription start sites, we found many more overlapping genes. A summary of this analysis is presented in [Supplementary Figure 2 and Tables 5--8](#appsec1){ref-type="sec"}. In short, 147 genes were found to be differentially expressed and associated with differentially methylated CpGs. Importantly, a ToppGene [@bib33] gene enrichment analysis of these 147 genes found many differentially methylated and expressed genes that also associated with diseases relevant to the metabolic syndrome [@bib34]. These results were reassuring and we proceeded with interrogation of the 7 genes in [Figure 1](#fig1){ref-type="fig"}.

Two of these genes were confirmed to have significant decreases in RNA expression after a high fat diet as determined by RT-PCR, and *Onecut1* was not significantly different but trended down with a p value of 0.07 ([Figure 1](#fig1){ref-type="fig"}B). The other genes trended by RT-PCR in a qualitatively similar manner to the RNA-seq data with the exception of *Scara5*, which was increased in RNA-seq (with corresponding hypomethylation) but decreased by RT-PCR. The differential methylation near the TSS of these genes can be seen in screenshots from the UCSC genome browser \[<http://genome.ucsc.edu> [@bib35]\] in [Figure 1](#fig1){ref-type="fig"}C. Summaries of these genes, along with a brief description of their functions, are listed in [Supplemental Table 5](#appsec1){ref-type="sec"}. Of note is that *Onecut1* and *Foxa3* are both important for liver development [@bib17], [@bib18], and the *Phlda1* global knockout model presents with a phenotype of increased adult body mass and liver steatosis, even on a standard chow diet [@bib19].

If genes were regulated by hypermethylation, such that increased promoter methylation decreases gene expression, then hypomethylation might reasonably be expected to increase the expression of that gene [@bib36]. To test this possibility for our target genes, we treated mouse primary hepatocytes overnight with a vehicle control or with 5-azacytodine, an agent that removes DNA methylation [@bib37]. We found that *Phlda1*, *Foxa3*, and *Onecut1* all displayed increased expression after 5-azacytidine treatment ([Figure 2](#fig2){ref-type="fig"}A).

To test if the differential RNA expression was due to transcriptional regulation we first measured the relative abundance of pre-mRNA of several genes, including *Phlda1*, *Onecut1*, and *Foxa3* ([Figure 2](#fig2){ref-type="fig"}B). Pre-mRNA levels were determined by RT-PCR using primers that spanned intron-exon boundaries after insuring that no DNA was present. This readout represents newly transcribed mRNA that has not yet been spliced. We found that *Onecut1* pre-mRNA significantly decreased after a high fat diet, *Phlda1* trended downward, and *Foxa3* pre-mRNA expression did not change. These results suggested that the decreased *Foxa3* mRNA was due to a post-transcriptional mechanism, while the decreases in *Onecut1* and *Phlda1* mRNA were more likely due to transcriptional mechanisms.

3.2. Transcriptional validation {#sec3.2}
-------------------------------

To confirm that hypermethylation from a high fat diet is associated with changes in transcription, we performed chromatin immunoprecipitation (ChIP) assays using antibodies against RNA pol II and the phosphorylated C-terminal domain of RNA pol II ([Figure 3](#fig3){ref-type="fig"}). Transcription proceeds after recruitment of the RNA pol II holocomplexes and often results in pausing approximately 20--60 bp downstream of the TSS [@bib38]. Here, the C-terminal domain, comprising approximately 50 heptad repeats of a conserved sequence (Y~1~S~2~P~3~T~4~S~5~P~6~S~7~), and with serine phospho-acceptor sites at positions 2 and 5, is critical for regulation of the polymerase. Phosphorylation of Ser5 of the CTD by TFIIH occurs after binding and before elongation of the RNA pol II complex while a second phosphorylation event mediated by CTDK1 of PTEFb on Ser2 occurs after release from pausing and during transcriptional elongation [@bib39]. Thus, by examining the relative recovery of RNA pol II, and CTD Ser5 and Ser2 from chromatin immunoprecipitates along a gene, from promoter to polyA signal, one is able to reconstruct the procession of RNA pol II through the gene (see [Figure 3](#fig3){ref-type="fig"}A) [@bib40]. In [Figure 3](#fig3){ref-type="fig"}B,C we found that *Phlda1* is transcribed in a typical fashion after a standard chow diet with abundant RNA pol II in the promoter region upstream and just downstream of the TSS in the 5′ region of exon 1 near the TSS, and less RNA pol II apparent in the second (last) exon of the gene. Likewise, the CTD Ser5 phosphorylation is most abundant at the 5′ regions of the gene, while CTD Ser2 phosphorylation is most abundant in the coding region and towards the 3′ end of the gene. There was a trend of decreased recovery of immunoprecipitated RNA pol II from chromatin isolated from mice fed a high fat diet compared to the standard chow diet at all of the sites interrogated, though this did not reach the level of statistical significance. However, the ratio of recovery of CTD Ser5 to total RNA pol II showed a very significant difference between the two diets ([Figure 3](#fig3){ref-type="fig"}C). Since the CTD of RNA pol II must be phosphorylated on Ser5 for release from pausing prior to elongation [@bib41], these data reflect a decrease in the transcriptional rate of this gene after a high fat diet. The pattern for *Onecut1* was similar, with RNA pol II most prominent near the 5′ end of the gene ([Figure 3](#fig3){ref-type="fig"}D), and with a pronounced decreased ratio (either significant or trending) of Ser5 phosphorylation to total RNA pol II after a high fat diet ([Figure 3](#fig3){ref-type="fig"}E). These data also reflect decreased transcription through the *Onecut1* gene. By contrast, the *Foxa3* gene displayed a more uniform distribution of RNA pol II ([Figure 3](#fig3){ref-type="fig"}F) and showed inconsistently decreased ratios of Ser5 phosphorylation to total RNA pol II only in exon 1 and at the end of exon 2 ([Figure 3](#fig3){ref-type="fig"}G). While there may be some transcriptional control, when combined with the pre-mRNA data, the main form of regulation of the *Foxa3* gene appears to be post-transcriptional. As a control, we measured RNA pol II occupancy of the β-*actin* housekeeping gene and found no change of recruitment near the promoter or in exons 1 or 3 with a HFD, consistent with a lack of transcriptional regulation ([Figure 3](#fig3){ref-type="fig"}H,I). We note that many genes increase in response to a HFD (165 genes increased greater than 2-fold with a p value less than 0.05), so there is not a general decrease in transcription in response to this diet.

3.3. Prioritization of candidate *Phlda1* gene targets *via* interrogation of an existing mouse Bayesian network {#sec3.3}
----------------------------------------------------------------------------------------------------------------

One of the most vexing problems for modern biologists is to decide which genes to interrogate after a whole genome analysis of differential gene regulation. We used a data-driven approach to identify a subnetwork of genes that may be influenced by perturbations in *Phlda1*. *Phlda1* is a node in an existing causal (Bayesian) network model of metabolic diseases (including obesity, diabetes and cardiovascular disease) that was assembled using liver transcriptome and genotype information scored in individuals of F2 mouse crosses of various strains and genotypes [@bib14], [@bib15], [@bib16]. As these Bayesian networks have proven effective in predicting causal gene--gene relationships [@bib42], [@bib43], [@bib44], we identified the subnetwork of genes comprising the nearest neighbors of *Phlda1* as in [Figure 4](#fig4){ref-type="fig"}A. Hepatic PHLDA1 was decreased after a high fat diet as determined by immunoblots ([Figure 4](#fig4){ref-type="fig"}B). We then evaluated each of the genes in the neighborhood in our RNA-seq dataset and noted that the highlighted genes in [Figure 4](#fig4){ref-type="fig"}A were found to be decreased by a high fat diet ([Figure 4](#fig4){ref-type="fig"}C). This strongly suggests that diet-induced changes in *Phlda1* transcription may in turn control expression of these genes. Notably, several of these genes are involved in liver phenotype, lipid homeostasis, and inflammation. With these molecular observations in hand, we proceeded to test if perturbing *Phlda1 in vivo* could account for at least part of the pathophysiological consequences of a high fat diet in liver.

3.4. *In vivo* validation {#sec3.4}
-------------------------

Global knock out of *Phlda1* presents with a phenotype that includes liver steatosis on a standard chow diet [@bib19]. We tested if liver-specific knock down of *Phlda1* was sufficient to alter liver phenotype. C57Bl/6 mice on a standard chow diet were injected with an adenovirus expressing shRNA directed against *Phlda1*. We found that 5 × 10^9^ PFU was sufficient to knock down hepatic *Phlda1* mRNA by approximately 80% and substantially decreased PHLDA1 at the protein level as well ([Figure 4](#fig4){ref-type="fig"}, [Figure 5](#fig5){ref-type="fig"}A). Furthermore, knockdown of *Phlda1* resulted in a general decrease in genes that were in the same local subnetwork as *Phlda1* ([Figure 4](#fig4){ref-type="fig"}C) including significant decreases in the expression of *Foxa1*, *Foxa2* and *Irx3* (Iroquois Homeobox 3, involved in neural development and also has been implicated in control of weight homeostasis, [@bib45]). These data support the idea that *Phlda1* is a key driver of the expression of the neighboring genes in the subnetwork. In addition, we tested if lipid content was altered after depletion of *Phlda1*. As shown in [Figure 5](#fig5){ref-type="fig"}B--D, whereas triglyceride levels and total Oil-red O staining were unchanged, livers from animals with the *Phlda1* knockdown displayed significantly increased lipid droplet size ([Figure 5](#fig5){ref-type="fig"}D). Increased lipid droplets in the liver can be an early indicator of liver steatosis [@bib46]. Together these data support the following interpretation presented as a model in [Figure 6](#fig6){ref-type="fig"}: a high-fat diet increases DNA methylation on select genes including the key driver gene, *Phlda1*, leading to decreased RNA polymerase activity, decreased gene transcription of *Phlda1*, and decreased expression of genes downstream in the Bayesian network, which led to increased lipid droplet size and contributed to the hepatic steatosis of a high fat diet.

4. Discussion {#sec4}
=============

Obesity is often associated with hepatic steatosis or fatty liver, which is on a spectrum of non-alcoholic fatty liver disease (NAFLD). NAFLD, if left unchecked, may progress to more inflammation and some fibrosis, identified pathologically as non-alcoholic steatohepatitis (NASH), and then to the more deadly cirrhosis or hepatocellular carcinoma [@bib47]. With the worldwide epidemic in obesity and diabetes, it is estimated that hundreds of millions of people have steatosis and are therefore at risk for advanced NAFLD, including cirrhosis and cancer [@bib48]. The molecular mechanisms underlying the pathophysiology of the disease are not completely understood. In the current study, we hypothesized that DNA methylation is altered in response to a high fat diet and that this epigenetic mechanism contributes to the pathophysiology of steatosis.

We found a set of genes that were hypermethylated and differentially underexpressed after 14 weeks on a high fat diet, including *Phlda1*, *Onecut1*, and *Foxa3*. PHLDA1 has 2 plextrin homology domains and polyglutamine domains suggestive of being a transcription factor [@bib49]. *Phlda1* is expressed in a wide variety of tissues and is found in different cellular compartments, including the nucleus, cytoplasm and endoplasmic reticulum. However, the exact biochemical role and mechanism of action of PHLDA1 is poorly elucidated. *Phlda1* appears to influence apoptosis and proliferation in cancer, but in a complex and tissue-specific manner [@bib49], [@bib50], [@bib51]. For example, *Phlda1* expression is reduced in melanoma and breast cancer but expressed at high levels in colon cancer and osteosarcomas [@bib49]. Notably, global *Phlda1* knockout mice have a phenotype with increased body mass and hepatic steatosis on a standard chow diet [@bib19]. *Onecut1* plays an important role in liver development and is conspicuous by often being associated with hepatic transcription factor networks that include the FOXA proteins, including FOXA3 [@bib18], [@bib52]. *Foxa3* has functional redundancy with *Foxa1* and *Foxa2* in the liver, and liver-specific knock down of *Foxa3* results in a relative hypoglycemia during a prolonged fast [@bib53].

Increased DNA methylation, particularly in promoter and enhancer regions enriched with CpG islands, is often accompanied with decreased expression of the associated gene, with the assumption that transcription factors have reduced binding at elements containing methylated CpGs and that transcription is reduced on these genes [@bib5]. However, the exact molecular mechanisms of altered gene expression via increased DNA methylation are rarely explained or validated. Here we found that a high fat diet in mice led to hypermethylation of DNA near the TSSs of several genes that also underwent significant decreases in RNA expression. Additionally, in genes that were regulated at the transcriptional level via the analysis of pre-mRNA expression (*Phlda1* and *Onecut1*), increased DNA methylation was accompanied by decreased activation and transcriptional procession of RNA polymerase in response to a high fat diet. Numerous studies have shown differential expression of genes related to lipid homeostasis and inflammation as a signature of the consequences of a high fat diet [@bib54], [@bib55], [@bib56]. However, relatively few studies have correlated changes in DNA methylation with changes in gene expression and, of those, most involve the inheritance of epigenetic marks and altered gene expression from high fat diets consumed by the mother [@bib57] or father [@bib58], or involved the restoration of DNA methylation with nutritional supplements that augment one carbon metabolism, such as folate or betaine [@bib59], [@bib60]. Recently, Murphy et al. evaluated the changes in DNA methylation and corresponding gene expression in humans with varying degrees of NAFLD, defined and measured from liver biopsies [@bib61]. This study focused on hypomethylated genes and the correspondingly increased expression of genes involved in the pathogenesis of NAFLD. (Note, while some genes are similar in function, tissue repair for example, the actual genes were different.) By comparison, our study focused on genes that were hypermethylated and decreased with the high fat diet.

We found that knockdown of *Phlda1* in mouse liver for 2 weeks, using an adenovirus expressing a specific shRNA, resulted in downregulation of all of the nearest neighbor candidate genes predicted by a mouse population based liver molecular network. Importantly, all of the genes in the subnetwork were significantly decreased after a high fat diet as determined by RNAseq (see comparison, [Supplemental Table 5](#appsec1){ref-type="sec"}). Included in this gene list were *Foxa1* and *Foxa2*, paralogs of *Foxa3*, which are required for liver development and are important for the expression of numerous metabolic enzymes involved in glucose and lipid homeostasis [@bib17]. Also included was *Irx3*, which is involved in weight homeostasis in the hypothalamus, though its role in the liver is not fully understood [@bib45]. Finally, the *Socs2* (Suppressor Of Cytokine Signaling 2) and *Cish* (Cytokine Inducible SH2 Containing Protein) genes express anti-inflammatory proteins. Decreased expression of these genes should promote inflammation, a hallmark of obesity and liver steatosis [@bib62].

Knockdown of *Phlda1* conferred a phenotype that included increased lipid droplet size. Altered lipid droplets in the liver suggest a deficiency in lipid droplet turnover and may be an early manifestation of liver steatosis [@bib46]. Mice treated with adenovirus expressing an shRNA directed against *Phlda1* did not display frank steatosis as in the global knockout animal [@bib19]. We suspect that the loss of *Phlda1* in additional tissues, such as fat, and the lifelong absence of *Phlda1* in the global knockout animal contributed to the stronger phenotype seen in the knockout animals. Our model proposes that decreased expression of *Phlda1* decreases other genes involved in liver function and lipid homeostasis, and, indeed, knocking down Phlda1 with adenovirus led to a decrease in Foxa1. In support of this idea, Moya et al. demonstrated that Foxa1 controls lipid accumulation in rat and human hepatocytes, with increased Foxa1 depleting hepatocytes via several mechanisms including synthesis and storage of triglycerides [@bib63]. Conversely, samples of liver with nonalcoholic fatty liver displayed reduced expression of Foxa1.

Several key questions arise from our study. How much time on a high fat diet is required to initiate gene-specific DNA methylation, alterations in downstream network genes, and liver phenotype? Another important question is the plasticity of the response. Once methylated by a high fat diet, can the DNA be demethylated by reversion to a standard chow or a calorically restricted diet? If so, how long does it take? Careful time course experiments and experiments switching from a high fat diet to a standard chow or low caloric diet will be needed to answer these important questions.

In summary, we found that 14 weeks on a high fat diet leads to hypermethylation and decreased expression of a relatively small set of genes. Among these were *Onecut1* and *Phlda1*, which we confirmed displayed decreased RNA pol II activation in the coding regions of their genes, consistent with decreased transcription. A subnetwork was generated using *Phlda1* and its nearest neighbors from an existing Bayesian gene expression network [@bib15]. Strikingly, knockdown of *Phlda1* decreased expression of the regulatory genes in the subnetwork and increased lipid droplet size, consistent with the whole body knockout phenotype, which includes hepatic steatosis. We conclude that a high fat diet alters the epigenetics of hepatocytes, contributing to the pathophysiology of obesity.
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![**RNA-seq and DNA Methyl-seq of standard chow- and high fat--fed mouse livers.** A. Venn diagram of genes found to be significantly differentially methylated within 1,000 bp of their TSS, and those with significantly different RNA expression in response to a high fat diet. B. Quantitative RT-PCR of the 7 genes plus *Onecut1* added due to remarkable number of hypermethylated CpGs and important role in liver development. N = 7, \*, p \< 0.05. C. Screenshots of UCSC genome browser showing significantly hypermethylated sites (blue bars, circled in green) near the TSSs of the indicated genes (oriented with upstream regions to the left). MethDiff, average percentage differentially methylated CpGs; blue bars, hypermethylated, red bars hypomethylated. <http://genome.ucsc.edu>[@bib35].](gr1){#fig1}

![**Genes potentially regulated by methylation status, transcriptional and post-transcriptional mechanisms.** A. Primary mouse hepatocytes were treated with 10 μM 5-azacytodine (Aza) for 18 h. Total RNA was collected and mRNA was measured using RT-PCR with primers for the indicated genes relative to β-actin using the ΔΔCT method. B. Measurement of pre-mRNA of *Phlda1*, *Onecut1*, and *Foxa3* using DNase-treated RNA and primers specifically spanning intron/exon boundaries. Error bars represent SEM, \*, p \< 0.05, N = 7.](gr2){#fig2}

###### 

**Molecular validation of transcriptional regulation.** A. Schematic of chromatin immunoprecipitation experiment. A time line is included: (1) RNA polymerase in recruited to the gene and pauses approximately 40 bp from the transcription start site; (2) the heptad repeat of the C-terminal domain (CTD) is "primed" by phosphorylation on Ser5; (3) Ser2 is phosphorylated and Ser5 is gradually dephosphorylated, allowing efficient transcriptional elongation; (4). Notably, *Phlda1*, *Onecut1*, and *Foxa3* all have only 2 exons. B--I. Chromatin immunoprecipitation was performed using antibodies against total RNA pol II, C-terminal domain (CTD) phospho-Ser5, CTD phospho-Ser2, and control IgG. B,D,F,H. Data shown were generated from quantitative PCR using primers specific for the indicated regions of the indicated genes. Shown is the signal as a percentage of input after subtraction of the IgG control. C, E, G, I. Data shown are the mean of the ratio between the signal from the CTD phospho-Ser5 and total RNA pol II signals at the indicated region of the indicated gene. Error bars represent SEM, \*, p \< 0.05, N = 6--7.
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![**Generation of a subnetwork from an existing Bayesian network of obese mouse liver**. A. A diagram of the small subnetwork immediately surrounding *Phlda1* (green) generated from an existing Bayesian gene expression network that was assembled using liver transcriptome and genotype information scored in individuals of F2 mouse crosses [@bib14], [@bib15], [@bib16]. Nearest neighbors that were interrogated further by RT-PCR are highlighted in blue. B. Representative immunoblots of liver extracts from mice on a standard chow or high fat diet using antibodies against PHLDA1 or β-ACTIN. C. Mean of fold change comparing high fat diet (HF) to standard chow diet (SC), or intraorbital injection of control (GFP) to sh-*Phlda1*-expressing adenovirus, using data from RNA-seq or RT-PCR, respectively. N = 5--7, \*p \< 0.05.](gr4){#fig4}

![**Knockdown of *Phlda1* inhibits expression of candidate target genes and increases lipid droplet size in mouse liver.** Adenoviruses expressing shRNA against *Phlda1*, or a control adenovirus, were injected retro-orbitally into C57/Bl6 mice on a standard chow diet. Two weeks later, liver sections were prepared for immunoblots using antibodies against PHLDA1 or β-ACTIN (A) and stained with Oil Red O (B). The concentration of triglycerides in liver tissue was measured using a kit (C). The average size of the Oil-red O stained particles was quantified using Image J software (D). Data are the mean ± SEM. \*, p \< 0.05; N = 5.](gr5){#fig5}

![**Model depicting how high fat diet affects DNA methylation, gene expression, and steatosis.** A high fat diet results in hypermethylation and decreased mRNA and pre-mRNA levels of specific genes, including *Phlda1*. The hypermethylation results in decreased transcription, providing a mechanistic explanation for decreased RNA expression. *Phlda1* was found to be a key driver controlling a small set of genes including *Foxa1*, *Foxa2*, and *Irx3*. These genes are known to be involved in liver function, lipid homeostasis, and inflammation. Knockdown of *Phlda1* resulted in larger lipid droplets in standard chow fed mice, an early manifestation of liver steatosis.](gr6){#fig6}

[^1]: Current address: Pediatric Cardiology, Morgan Stanley Children\'s Hospital, Columbia University Medical Center of New York Presbyterian, USA.
